What a year! Perspectives has explored a myriad of topics this year — from adaptive trial design to advice on regulatory submission to clinical data best practices, and so much more — all written by our many expert authors. ✨ As we approach the end of the year, here is a list of our most-read articles of 2023: https://bit.ly/47blq2X 👏 A big thank you to all of the authors represented in these posts: Ari Brettman (Blackstone Life Sciences), Louis Dron, Scott Gaines, Miguel Hernán (Harvard University), Åsa Holmgren, Vinusha Kalatharan, Florence Le Maulf, Emma Mackay, James Matcham, Cyrus Mehta, Evie Merinopoulou, Natalia Muehlemann, Iffat Rahman, Grammati Sarri, Jason Simeone, Angelo Tinazzi, and Pantelis Vlachos! 👏 #pharma #pharmaceuticalindustry #biotech #realworldevidence #RWE #realworlddata #RWD #FDA #clinicaltrials #clinicaldevelopment #regulatoryaffairs #FDA #oncology #Bayesian #adaptivetrials #software #technology #CDISC #data
